Dirk Hoffmann

1.3k citations

28 papers · 762 indexed · h-index 16

Impact in

Virology top 10%
- HIV Research and Treatment
Immunology
- Immune cells in cancer

Papers in ⓘ

Genetics 14
- Virus-based gene therapy research 11
Virology 2
- HIV Research and Treatment 2

Co-authors: Axel Schambach (25 shared papers)Thomas Moritz (5 shared papers)Nico Lachmann (5 shared papers)Doris Steinemann (8 shared papers)Mania Ackermann (3 shared papers)Joachim Hauber (2 shared papers)Carina Banning (2 shared papers)Michael Schindler (2 shared papers)
Journals: Stem Cell Reports (4 papers)Human Gene Therapy (3 papers)Gene Therapy (3 papers)Molecular Therapy (2 papers)PLoS ONE (2 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Dirk Hoffmann

28 papers receiving 750 citations

Peers

Countries citing papers authored by Dirk Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Dirk Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Hoffmann more than expected).

Fields of papers citing papers by Dirk Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Hoffmann. The network helps show where Dirk Hoffmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Dirk Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dirk Hoffmann Line = papers co-authored together Dirk Hoffmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies Stem Cell Reports ·Nico Lachmann, Mania Ackermann, Eileen Frenzel, Steffi Liebhaber, Sebastian Brennig, Christine Happle, Dirk Hoffmann, Olga Klimenkova, Doreen Lüttge, Theresa Buchegger, Mark Kühnel, Axel Schambach, Sabina Janciauskiene, Constança Figueiredo, Gesine Hansen, Julia Skokowa, Thomas Moritz	2015	145
2	A Flow Cytometry-Based FRET Assay to Identify and Analyse Protein-Protein Interactions in Living Cells PLoS ONE ·Carina Banning, Jörg Votteler, Dirk Hoffmann, Herwig Koppensteiner, Martin Warmer, Rudolph Reimer, Frank Kirchhoff, Ulrich S. Schubert, Joachim Hauber, Michael Schindler	2010	122
3	TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells Biomaterials ·Anne-Kathrin Dreyer, Dirk Hoffmann, Nico Lachmann, Mania Ackermann, Doris Steinemann, Barbara Timm, Ulrich Siler, Janine Reichenbach, Manuel Grez, Thomas Moritz, Axel Schambach, Toni Cathomen	2015	57
4	Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells Gene Therapy ·Dirk Hoffmann, Juliane W. Schott, Franziska K. Geis, Lucas Lange, Frank Müller, Dominic Lenz, Daniela Zychlinski, Doris Steinemann, Michael Morgan, Thomas Moritz, Axel Schambach	2017	39
5	Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG) Molecular & Cellular Proteomics ·Christina T. Thiesler, Samanta Cajic, Dirk Hoffmann, Christian Thiel, Laura van Diepen, René Hennig, Malte Sgodda, Robert Weiβmann, Udo Reichl, Doris Steinemann, Ulf Diekmann, Nicolas Huber, Astrid Oberbeck, Tobias Cantz, Andreas W. Kuß, Christian Körner, Axel Schambach, Erdmann Rapp, Falk F. R. Buettner	2016	38
6	Differential Transgene Silencing of Myeloid-Specific Promoters in the AAVS1 Safe Harbor Locus of Induced Pluripotent Stem Cell-Derived Myeloid Cells Human Gene Therapy ·Denise Klatt, Erica Cheng, Dirk Hoffmann, Giorgia Santilli, Adrian J. Thrasher, Christian Brendel, Axel Schambach	2019	34
7	Adjuvant Gemcitabine Therapy Improves Survival in A Locally Induced, R0-Resectable Model of Metastatic Intrahepatic Cholangiocarcinoma Hepatology ·Engin Gürlevik, Bettina Fleischmann-Mundt, Nina Armbrecht, Thomas Longerich, Norman Woller, Arnold Kloos, Dirk Hoffmann, Axel Schambach, Thomas Wirth, Michael P. Manns, Lars Zender, Stefan Kubicka, Florian Kühnel	2013	31
8	Inducible Forward Programming of Human Pluripotent Stem Cells to Hemato-endothelial Progenitor Cells with Hematopoietic Progenitor Potential Stem Cell Reports ·Lucas Lange, Dirk Hoffmann, Adrian Schwarzer, Teng-Cheong Ha, Friederike Philipp, Daniela Lenz, Michael Morgan, Axel Schambach	2019	29
9	Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous Pseudogenes Stem Cell Reports ·Denise Klatt, Erica Cheng, Friederike Philipp, Anton Selich, Julia Dahlke, Reinhold E. Schmidt, Juliane W. Schott, Hildegard Büning, Dirk Hoffmann, Adrian J. Thrasher, Axel Schambach	2019	25
10	A three-dimensional measure of surface roughness based on mathematical morphology International Journal of Machine Tools and Manufacture ·J. Schmähling, Fred A. Hamprecht, Dirk Hoffmann	2006	23
11	Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells Human Gene Therapy ·L. Zhang, Axel Rossi, Lucas Lange, Nadja Meumann, Ulrike Koitzsch, Kathleen A. Christie, M. Andrew Nesbit, Casey Moore, Ulrich Hacker, Michael Morgan, Dirk Hoffmann, James Zengel, Jan E. Carette, Axel Schambach, Anna Salvetti, Margarete Odenthal, Hildegard Büning	2019	22
12	Modified Lentiviral LTRs Allow Flp Recombinase–mediated Cassette Exchange and In Vivo Tracing of “Factor-free” Induced Pluripotent Stem Cells Molecular Therapy ·Johannes Kuehle, Soeren Turan, Tobias Cantz, Dirk Hoffmann, Julia D. Suerth, Tobias Maetzig, Daniela Zychlinski, Christoph Klein, Doris Steinemann, Christopher Baum, Juergen Bode, Axel Schambach	2014	20
13	Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform Molecular Therapy ·Juwita Hübner, Shahabuddin S Hoseini, Julia D. Suerth, Dirk Hoffmann, Marcel Maluski, Jessica Herbst, Holger Maul, Arnab Ghosh, Britta Eiz‐Vesper, Qinggong Yuan, Michael Ott, Michael Heuser, Axel Schambach, Martin G. Sauer	2016	20
14	Formation of Trans-Activation Competent HIV-1 Rev:RRE Complexes Requires the Recruitment of Multiple Protein Activation Domains PLoS ONE ·Dirk Hoffmann, Doreen Schwarck, Carina Banning, Matthias Brenner, M. Lakshmikanth, Marcel Krepstakies, Michael Schindler, David P. Millar, Joachim Hauber	2012	20
15	A patient-specific induced pluripotent stem cell model for West syndrome caused by ST3GAL3 deficiency European Journal of Human Genetics ·Laura van Diepen, Falk F. R. Buettner, Dirk Hoffmann, Christina T. Thiesler, Oliver von Bohlen und Halbach, Viola von Bohlen und Halbach, Lars R. Jensen, Doris Steinemann, Simon Edvardson, Orly Elpeleg, Axel Schambach, Rita Gerardy‐Schahn, Andreas W. Kuß	2018	17
16	Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells Retrovirology ·Franziska K. Geis, Melanie Galla, Dirk Hoffmann, Johannes Kuehle, Daniela Zychlinski, Tobias Maetzig, Juliane W. Schott, Adrian Schwarzer, Christine Goffinet, Stephen P. Goff, Axel Schambach	2017	16
17	Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells Molecular Therapy — Nucleic Acids ·Yvonne Baron, Johanna Sens, Lucas Lange, Larissa Nassauer, Denise Klatt, Dirk Hoffmann, Marc‐Jens Kleppa, Philippe Vollmer Barbosa, Maximilian Keisker, Viviane Steinberg, Julia D. Suerth, Florian W. R. Vondran, Johann Meyer, Michael Morgan, Axel Schambach, Melanie Galla	2022	13
18	A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML International Journal of Molecular Sciences ·Jacob Jalil Hassan, Anna Lieske, Nicole Dörpmund, Denise Klatt, Dirk Hoffmann, Marc‐Jens Kleppa, Olga Kustikova, Maike Stahlhut, Adrian Schwarzer, Axel Schambach, Tobias Maetzig	2021	13
19	Knockout-Induced Pluripotent Stem Cells for Disease and Therapy Modeling of IL-10-Associated Primary Immunodeficiencies Human Gene Therapy ·Johanna Sens, Dirk Hoffmann, Lucas Lange, Philippe Vollmer Barbosa, Michael Morgan, Christine S. Falk, Axel Schambach	2020	12
20	Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells Gene Therapy ·Dirk Hoffmann, Johannes Kuehle, Daniela Lenz, Friederike Philipp, Daniela Zychlinski, Nico Lachmann, Thomas Moritz, Doris Steinemann, Michael Morgan, Julia Skokowa, Christoph Klein, Axel Schambach	2020	10

About Dirk Hoffmann

Dirk Hoffmann is a scholar working on Genetics, Virology, Molecular Biology, Immunology and Hematology, having authored 28 papers that have together received 762 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (15 papers), Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (10 papers), Pluripotent Stem Cells Research (6 papers), Advanced biosensing and bioanalysis techniques (3 papers), Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Virology (50 citations), Immunology (184 citations), Molecular Biology (490 citations), Genetics (194 citations) and Oncology (139 citations). Dirk Hoffmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Axel Schambach, Thomas Moritz, Nico Lachmann, Doris Steinemann, Mania Ackermann, Joachim Hauber, Carina Banning, Michael Schindler, Michael Morgan and Herwig Koppensteiner. Their work appears in journals such as Stem Cell Reports, Human Gene Therapy, Gene Therapy, Molecular Therapy and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact